AMERICAN BIOGENETIC SCIENCES INC
PRES14A, 1998-09-21
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IBIS TECHNOLOGY CORP, 8-K, 1998-09-21
Next: PRINCETON DENTAL MANAGEMENT CORP, 8-K, 1998-09-21






                           Preliminary Proxy Statement  
                            SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant [X]

Filed by a party other than the Registrant [   ]

Check the appropriate box:

[X]  Preliminary Proxy Statement
[ ]  Confidential,  for  Use  of the  Commission  Only  (as  permitted  by  Rule
     14a-6(e)(2)
[ ] Definitive Proxy Statement
[ ] Definitive  Additional Materials
[ ] Soliciting Material Pursuant to ss.240.14a-11(c) or ss.240.14a-12

                       American Biogenetic Sciences, Inc.
                ------------------------------------------------
                (Name of Registrant as Specified in Its Charter)


    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X]      No fee required

[ ]      Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11

         1) Title of each class of securities to which transaction applies:

         2) Aggregate number of securities to which transaction applies:

         3) Per  unit  price  or other  underlying  value  of  transaction
            computed  pursuant  to  Exchange  Act Rule 0-11 (Set forth the
            amount on which the filing fee is calculated  and state how it
            was determined):

         4) Proposed maximum aggregate value of transaction:

         5) Total fee paid:

[ ]      Fee paid previously with preliminary materials.

[ ]      Check box if any part of the fee is offset as  provided  by  Exchange
         Act Rule  0-11(a)(2)  and identify the filing for which the  offsetting
         fee was paid  previously.  Identify the previous filing by registration
         statement number, or the Form or Schedule and the date of its filing.

         1)       Amount Previously Paid:

         2)       Form, Schedule or Registration Statement No.:

         3)       Filing Party:

         4)       Date Filed:

<PAGE>

                           Preliminary Proxy Statement
                              

                       AMERICAN BIOGENETIC SCIENCES, INC.

                                1375 Akron Street
                            Copiague, New York 11726
                              --------------------

                    NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
                              --------------------

                                November 11, 1998
                              --------------------

         NOTICE IS  HEREBY  GIVEN  that a Special  Meeting  of  Stockholders  of
American Biogenetic Sciences, Inc., a Delaware corporation (the "Company"), will
be held at the Huntington Hilton, 598 Broad Hollow Road, Melville,  New York, on
Wednesday, November 11, 1998 at 10:30 a.m., Eastern Standard Time. The following
matters are to be presented for consideration at the meeting:

         1. Authorization of an Amendment to the Company's Restated  Certificate
of  Incorporation  in order to effect a combination  (reverse split) pursuant to
which  the  Company's  outstanding  shares  of Class A Common  Stock and Class B
Common Stock would be exchanged for new shares of Class A Common Stock and Class
B Common Stock,  respectively,  in an exchange ratio to be approved by the Board
of  Directors,  ranging from one newly  issued share for each three  outstanding
shares to one newly issued share for each six outstanding shares; and

         2. To approve the issuance,  in addition to the up to 4,000,000  shares
of Class A Common Stock which the Company has agreed to issue,  of all shares of
Class A Common  Stock  which  the  Company  would  be  entitled  to  issue  upon
conversion of the Company's 5% Convertible Debentures due May 20, 2001.

         3. The  transaction  of such other business as may properly come before
the meeting or any adjournments or postponements thereof.

         The close of  business  on  September  25,  1998 has been  fixed as the
record date for the determination of stockholders  entitled to notice of, and to
vote at, the meeting and any  adjournments or postponements  thereof.  A list of
such  stockholders  will be open  for  examination  by any  stockholder  for any
purpose germane to the meeting,  during ordinary business hours, for a period of
at least ten days prior to the meeting at the offices of the Company, 1375 Akron
Street, Copiague, New York.

                                       By Order of the Board of Directors,

                                            /s/    Timothy J. Roach

                                                   Timothy J. Roach
                                                   Secretary
Copiague, New York
October 2, 1998

WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING,  PLEASE COMPLETE, DATE AND SIGN
THE  ENCLOSED  PROXY AND MAIL IT PROMPTLY IN THE  ENCLOSED  ENVELOPE IN ORDER TO
ASSURE  REPRESENTATION  OF YOUR  SHARES.  NO  POSTAGE IS NEEDED IF MAILED IN THE
UNITED STATES.


<PAGE>

                           Preliminary Proxy Statement
                              
                       AMERICAN BIOGENETIC SCIENCES, INC.

                                1375 Akron Street
                            Copiague, New York 11726
                              --------------------

                                 PROXY STATEMENT
                              --------------------

         This Proxy  Statement  is  furnished  to the  holders of Class A Common
Stock  ("Class A Common  Stock") and to the sole holder of Class B Common  Stock
("Class B Common Stock" and, together with Class A Common Stock, "Common Stock")
of American  Biogenetic  Sciences,  Inc. (the  "Company") in connection with the
solicitation  by the  Board  of  Directors  of the  Company  of  proxies  in the
accompanying  form  ("Proxy" or  "Proxies")  to be used at a Special  Meeting of
Stockholders  of the Company (the  "Meeting") to be held on Wednesday,  November
11, 1998, at 10:30 a.m.,  Eastern Standard Time, at the Huntington  Hilton,  598
Broad Hollow Road, Melville, New York, and at any adjournments and postponements
thereof,  for the  purposes  set forth in the  accompanying  Notice  of  Special
Meeting.  It is  anticipated  that this Proxy  Statement and the Proxies will be
mailed to stockholders on or about October 2, 1998.  Proxies  properly  executed
and received in time for the Meeting will be voted. A stockholder  who signs and
returns a Proxy has the power to revoke it at any time before it is exercised by
giving written notice of revocation to the Company, 1375 Akron Street, Copiague,
New York 11726, Attention: Secretary, by a duly executed proxy of later date, or
by voting in person at the Meeting.

         The close of  business  on  September  25,  1998 has been  fixed as the
record date for the determination of stockholders  entitled to notice of, and to
vote at, the Meeting  (the "Record  Date").  There were  outstanding,  as of the
close of business on that date,  20,710,538  shares of Class A Common  Stock and
1,775,500  shares  of Class B Common  Stock.  A  majority  of the  total of such
outstanding shares of Class A Common Stock and Class B Common Stock, represented
in person or by Proxy at the Meeting, is required to constitute a quorum for the
transaction of business at the Meeting. Holders of Class A Common Stock have one
vote for each  share  thereof  held of record  and the  holder of Class B Common
Stock has ten votes for each share  thereof  held of record.  The Class A Common
Stock and Class B Common  Stock will vote as one class on all  matters  proposed
herein to be submitted to stockholders at the Meeting.

         Unless otherwise specified, all Proxies received will be voted in favor
of each of (i) authorization of the proposed Amendment to the Company's Restated
Certificate of Incorporation ( the "Amendment") in order to effect a combination
(the "Reverse Split") of each of the Company's  outstanding Class A Common Stock
and Class B Common Stock (the "Reverse Split Proposal") and (ii) approval of the
issuance,  in addition to the shares  which the Company has agreed to issue,  of
all shares of Class A Common Stock which the Company  would be entitled to issue
upon conversion of the Company's 5% Convertible Debentures due May 20, 2001 (the
"Additional Issuance Proposal"). The Board of Directors does not intend to bring
before the Meeting any matter other than those specifically  described above and
knows of no matters other than the foregoing to come before the Meeting.  If any
other  matters or motions  come before the Meeting,  it is the  intention of the
persons named in the  accompanying  Proxy to vote such Proxy in accordance  with
their  judgment on such matters or motions,  including any matters  dealing with
the conduct of the Meeting.

         Proxies submitted which contain  abstentions or broker nonvotes will be
deemed  present at the Meeting in determining  the presence of a quorum.  Shares
subject to abstentions with respect to any matter are considered shares entitled
to, and voted,  with respect to that matter.  Shares subject to broker  nonvotes
with respect to any matter are not  considered  as shares  entitled to vote with
respect to that matter.  Since, to adopt the Reverse Split Proposal requires the
affirmative  vote of a  majority  of the votes  represented  by all  outstanding
shares of Class A Common Stock and Class B Common  Stock,  voting  together as a
single class,  abstentions and broker non-votes will effectively  serve as votes
"against" the Reverse Split  Proposal.  With respect to the Additional  Issuance
Proposal,  abstentions  will, in effect,  be deemed negative  votes,  but broker
nonvotes will not affect the results of the vote thereon.

<PAGE>


                          SECURITY HOLDINGS OF CERTAIN
                      STOCKHOLDERS, MANAGEMENT AND NOMINEES

         The following  table sets forth  information as at the Record Date with
respect to the  beneficial  ownership of the Company's  Class A Common Stock and
Class B Common Stock by (i) each person known by the Company to beneficially own
more than 5% of the outstanding shares of Class A Common Stock or Class B Common
Stock,  (ii) each director of the Company,  (iii) the Company's  Chief Executive
Officer and each other executive officer whose annual cash compensation for 1997
exceeded  $100,000 and (iv) all executive  officers and directors of the Company
as a group. Each share of Class A Common Stock is entitled to one vote per share
while each share of Class B Common Stock is entitled to ten votes per share. The
Company  understands that, except as noted below, each beneficial owner has sole
voting and  investment  power with  respect to all shares  attributable  to such
owner.
<TABLE>
<CAPTION>

                                        Class A Common Stock(1)                      Class B Common Stock
                                        -----------------------                      --------------------

                                                          Percent                                      Percent
Beneficial Owner                        No. Shares        of Class                  No. Shares         of Class
- -----------------                      ------------       --------                  ----------         --------

<S>                               <C>                <C>                       <C>                  <C> 
Alfred J. Roach (2)                    3,870,750  (2)       16.4%                     1,775,500            100%

Stephen H. Ip                            105,001  (3)           *                           ---            ---

Ellena M. Byrne                          212,500  (3)(4)     1.0%                           ---            ---

Timothy J. Roach                         617,500  (3)        2.9%                           ---            ---

Josef C. Schoell                         127,750  (3)           *                           ---            ---

Gustav V. R. Born                         23,750  (3)           *                           ---            ---

Joseph C. Hogan                           50,000  (3)           *                           ---            ---

William G. Sharwell                       45,000  (3)           *                           ---            ---

All executive officers and directors
  as a group (11 persons, including
   the foregoing)                      5,239,251  (5)        21.0%                    1,775,500            100%
- ----------------------------
</TABLE>


(1)      Asterisk  indicates  less  than one  percent.  Shares of Class A Common
         Stock subject to issuance upon  conversion of Class B Common Stock into
         Class A Common Stock and upon exercise of options that were exercisable
         on, or become  exercisable  within 60 days  after,  the Record Date are
         considered  owned by the holder thereof and outstanding for purposes of
         computing the percentage of outstanding Class A Common Stock that would
         be owned by such person,  but (except for the computation of beneficial
         ownership by all  executive  officers and directors as a group) are not
         considered  outstanding  for purposes of computing  the  percentage  of
         outstanding Class A Common Stock owned by any other person.

(2)      The address of Mr. Roach is Route 2 - Kennedy Avenue, Guaynabo,  Puerto
         Rico  00657.  Beneficial  ownership  of Class A Common  Stock  includes
         1,775,500  shares of Class A Common Stock  issuable upon  conversion of
         the same number of shares of Class B Common  Stock on a share for share
         basis  and  1,160,000  shares  of  Class  A  Common  Stock  subject  to
         outstanding options.

(3)      Includes  shares of Class A Common Stock subject to options as follows:
         Stephen H. Ip,  100,001;  Ellena M. Byrne,  172,500  (including  15,000
         shares  subject  to options  held by her  husband);  Timothy J.  Roach,
         607,500; Josef C. Schoell, 118,750; Gustav V.R. Born, 23,750; Joseph C.
         Hogan, 30,000; and William G. Sharwell, 35,000.

(4)      Includes 15,000 shares owned by Ms. Byrne's son. The inclusion of these
         amounts  should not be construed as an admission  that Ms. Byrne is the
         beneficial owner of these shares.

(5)      Includes  1,775,500  shares  of  Class A  Common  Stock  issuable  upon
         conversion  of the same  number of  shares of Class B Common  Stock and
         2,405,001  shares  of  Class A  Common  Stock  subject  to  outstanding
         options.


                                       -2-

<PAGE>
                                   PROPOSAL 1.

                   TO AUTHORIZE AN AMENDMENT TO THE COMPANY'S
                    RESTATED CERTIFICATE OF INCORPORATION TO
                     ENABLE THE BOARD OF DIRECTORS TO EFFECT
                  A REVERSE SPLIT OF EACH CLASS OF COMMON STOCK

General

         The Company's  Board of Directors has unanimously  adopted  resolutions
proposing,  declaring advisable and recommending that stockholders  authorize an
Amendment  to  the  Company's   Restated   Certificate  of  Incorporation   (the
"Amendment") to (i) effect a combination  (reverse stock split) of the Company's
issued  shares of Class A Common  Stock and Class B Common  Stock (the  "Reverse
Split") and (ii)  provide for the payment of cash in lieu of  fractional  shares
otherwise  issuable  in  connection  therewith.  There  will be no change in the
number of the  Company's  authorized  shares of Class A Common  Stock or Class B
Common Stock and no change in the par value of either class.

         If the Reverse Split is approved, the Board will have authority without
further  stockholder  approval to effect the Reverse Split pursuant to which the
Company's  outstanding  shares (the "Old  Shares")  of Class A Common  Stock and
Class B Common  Stock would be  exchanged  for new shares (the "New  Shares") of
Class A Common  Stock and Class B Common  Stock,  respectively,  in an  exchange
ratio to be approved by the Board of  Directors,  ranging from one New Share for
each  three Old Shares to one New Share for each six Old  Shares.  The number of
Old Shares for which each New Share is to be  exchanged  is  referred  to as the
"Exchange Number". The Exchange Number may, within such range, be a whole number
or a whole  number and  fraction of a whole  number.  The Reverse  Split will be
effected  simultaneously  for each of Class A Common  Stock  and  Class B Common
Stock and Exchange Number will be the same for each class.

         In addition,  the Board will have the  authority to determine the exact
timing of the effective date of the Reverse  Split,  which may be any time prior
to June 30, 1999, without further stockholder approval. Such timing and Exchange
Number will be determined  in the judgment of the Board of  Directors,  with the
intention of maximizing the Company's  ability to remain in compliance  with the
continued  listing  maintenance  requirements  of The Nasdaq Stock Market,  Inc.
("Nasdaq") and other intended  benefits of the Reverse Split to stockholders and
the  Company.  See  "--Purpose  of the Reverse  Split,"  below.  The text of the
proposed  Amendment  (subject to  inserting  the  effective  date of the Reverse
Split,  the Exchange  Number and the per share amount to be paid for  fractional
shares) is set forth in Exhibit A to this Proxy Statement.

         The  Board  of  Directors  also  reserves  the  right,  notwithstanding
stockholder  approval and without  further  action by the  stockholders,  to not
proceed with the Reverse  Split,  if, at any time prior to filing the  Amendment
with the Secretary of State of the State of Delaware, the Board of Directors, in
its sole discretion,  determines that the Reverse Split is no longer in the best
interests  of the  Company  and its  stockholders.  The Board of  Directors  may
consider a variety of factors in  determining  whether or not to  implement  the
Reverse Split and in determining the Exchange Number including,  but not limited
to, overall trends in the stock market, recent changes and anticipated trends in
the per share market price of the Company's  Class A Common Stock,  business and
transactional  developments  and the Company's  actual and  projected  financial
performance.

         The Reverse Split will not change the proportionate equity interests of
the  Company's  stockholders,  nor will the  respective  voting rights and other
rights of stockholders be altered, except for possible immaterial changes due to
the Company's purchase of fractional shares. The Common Stock issued pursuant to
the Reverse  Split will remain  fully paid and  nonassessable.  The Company will
continue to be subject to the periodic reporting requirements of the Securi ties
Exchange Act of 1934.

                                       -3-

<PAGE>



Purposes of the Reverse Split

         The  Company's  Class A Common  Stock is  quoted on  Nasdaq's  National
Market  ("Nasdaq/NMS").  In order for the Class A Common Stock to continue to be
quoted  thereon,  the  Company  and its  Class A Common  Stock are  required  to
continue to comply with various  listing  maintenance  standards  established by
Nasdaq.  Among other things,  as such requirements  pertain to the Company,  the
Company is  required to  maintain  an  adjusted  tangible  net worth of at least
$4,000,000  and its Class A Common Stock must have an aggregate  market value of
shares held by persons other than officers and directors  ("public float") of at
least $5,000,000, at least 400 persons who own at least 100 shares and a minimum
bid price of at least $1.00 per share.

         Under Nasdaq's listing maintenance standards,  if the closing bid price
of the Class A Common  Stock is under  $1.00 per share for a thirty  consecutive
business days and does not  thereafter  regain  compliance  for a minimum of ten
consecutive business days during the ninety calendar days following notification
by  Nasdaq,  Nasdaq may  delist  the Class A Common  Stock  from  trading on the
Nasdaq/NMS.  If this were to occur,  the Class A Common Stock would trade on the
OTC Bulletin Board or in the "pink sheets"  maintained by the National Quotation
Bureau,  Inc. Such  alternatives  are generally  considered to be less efficient
markets.  While the Company has not received any such  notification from Nasdaq,
the  closing  bid price of its Common  Stock has been below  $1.00 per share for
thirty  consecutive  days prior to September 30, 1998.  The Company  understands
that it is Nasdaq's position that an ability to demonstrate sustained compliance
is also required to achieve  compliance with this requirement.  Giving the Board
authority to implement  the Reverse  Split will avoid the need to call a special
meeting  of, or seek  consents  from,  stockholders  under time  constraints  to
authorize a reverse  split should  Nasdaq at a later date request the Company to
effectuate  a  reverse  split.  There  can  be no  assurance  that,  even  after
effectuating  the Reverse  Split,  the Company will continue to meet the minimum
bid price and other  requirements of Nasdaq for continued  inclusion for trading
on Nasdaq/NMS.

         The Company also  believes  that  effectuating  the Reverse  Split will
result in a broader market for the Company's Class A Common Stock and facilitate
the use of the Class A Common Stock in acquisitions  and financing  transactions
in which the Company may engage.  Many investors,  including  institutions,  are
reluctant to invest in, and many  brokerage  firms are reluctant to recommend to
their clients, lower-priced stocks. Additionally,  the policies and practices of
a number of brokerage houses tend to discourage  individual brokers within those
firms from dealing in lower-priced  stocks. Some of these policies and practices
pertain to the payment of broker's commissions and to time-consuming  procedures
that render the handling of lower-priced  stocks unattractive to brokers from an
economic perspective.  Moreover, the structure of trading commissions also tends
to have an adverse  impact  upon  holders of  lower-priced  stocks  because  the
brokerage  commission  payable  on the sale of a  lower-priced  stock  generally
represents  a higher  percentage  of the sales  price than the  commission  on a
relatively higher-priced issue. Furthermore, the policy of many brokerage houses
is not to make margin loans against lower priced stocks.

         The Board of Directors  hopes that the decrease in the number of shares
of Common Stock outstanding as a consequence of the Reverse Split will result in
an anticipated  corresponding  increased  price per share,  enabling the Class A
Common Stock to meet the requirements for continued listing on Nasdaq/NMS, while
becoming  more  attractive  to potential  investors.  There can be no assurance,
however,  that the Reverse  Split will  increase the market price of the Class A
Common  Stock by a  multiple  equal to the  Exchange  Number  or  result  in the
permanent  increase in the market price (which is dependent  upon many  factors,
including the Company's performance and prospectus).

                                       -4-

<PAGE>



Certain Effects of the Reverse Split

         The following  tables  illustrate the principal  effects of the Reverse
Split on the Company's Common Stock:

<TABLE>
<CAPTION>


                                        Prior to      After 1-for-3     After 1-for-4    After 1-for-5       After 1-for-6
                                     Reverse Stock    Reverse Stock     Reverse Stock    Reverse Stock       Reverse Stock
Number of Shares                         Split            Split             Split             Split           Split
- ----------------                     -------------    --------------    --------------   -------------       -------------------

<S>                                    <C>              <C>               <C>              <C>               <C>       
Class A Common Stock, .001 par
   value Authorized................       50,000,000       50,000,000        50,000,000       50,000,000        50,000,000
                                    
   Outstanding (1).................       20,710,538        6,903,512         5,177,634        4,142,107         3,451,756
   Available for Future Issuance...       29,289,462       43,096,488        44,822,366       45,857,893        46,548,244
Class B Common Stock
   Authorized......................        3,000,000        3,000,000         3,000,000        3,000,000         3,000,000
   Outstanding.....................        1,775,500          591,833           443,875          355,100           295,916
   Available for Future Issuance...        1,224,500        2,408,167         2,556,125        2,644,900         2,704,084
Financial Data (2)
Stockholders' Equity
   Class A Common Stock............  $        21,000 $          7,000  $          5,000  $         4,000  $          3,000
   Class B Common Stock............            2,000            1,000             1,000            1,000             1,000
   Additional Paid-in Capital             58,773,000       58,788,000        58,790,000       58,791,000        58,792,000
Deficit Accumulated During
   Development Stage...............      (52,328,000)     (52,328,000)      (52,328,000)     (52,328,000)      (52,328,000)
                                         ------------     ------------      ------------     ------------      ------------
   Total Stockholders' Equity......   $    6,468,000 $      6,468,000  $      6,468,000   $    6,468,000  $      6,468,000
                                        ============     ==============    ==============    ============     ==============
Net (Loss) per share:
   Six months ended June 30, 1998            $(0.14)          $(0.41)           $(0.54)          $(0.68)           $(0.81)
   Year ended December 31, 1997              $(0.35)          $(1.06)           $(1.41)          $(1.77)           $(2.12)
   Book Value Per Common
     Share.........................            $0.31            $0.94             $1.25            $1.56             $1.87
   -----------------------------

</TABLE>

(1)      Gives effect to the Reverse Split as if it occurred on the Record Date,
         subject to  adjustment  resulting  from the  repurchase  of  fractional
         shares.  Excludes,  on a pre-Reverse  Split basis,  1,775,500 shares of
         Class A Common Stock subject to potential  issuance upon  conversion of
         the  outstanding  shares of Class B Common Stock;  4,678,541  shares of
         Class A Common  Stock  which were  subject to  outstanding  options and
         warrants;;  1,405,750  additional  shares of Class A Common Stock which
         were  available  for the grant of future  options  under the  Company's
         stock  option  plans;  up to  4,000,000  shares of Class A Common Stock
         which  were  subject  to  potential  issuance  upon  conversion  of the
         Debentures  (see  "APPROVAL  OF  ISSUANCE  OF  ADDITIONAL  SHARES  UPON
         CONVERSION OF 5%  CONVERTIBLE  DEBENTURES");  and  1,332,910  shares of
         Class A Common Stock reserved for potential issuance upon conversion of
         other debentures. Upon effectiveness of the Reverse Split, each option,
         warrant  and  conversion  right  would  entitle the holder to acquire a
         number of shares  equal to the  number of shares  which the  holder was
         entitled to acquire  prior to the Reverse Split divided by the Exchange
         Number at the exercise or conversion price in effect  immediately prior
         to the Reverse Split multiplied by the Exchange Number.

(2)      Balance  sheet data gives effect to the Reverse Split as if it occurred
         on June 30, 1998,  subject to adjustment  resulting from the repurchase
         of fractional shares.


                                       -5-

<PAGE>




         Stockholders  should recognize that if the Reverse Split is effectuated
they will own a fewer number of shares than they  presently own - a number equal
to the number of shares owned  immediately  prior to the filing of the Amendment
divided  by the  Exchange  Number and that  there can be no  assurance  that the
market  price of the  Company's  Common  Stock  will,  in fact,  correspondingly
increase by a multiple equal to the Exchange  Number  following  consummation of
the Reverse  Split or, even if such price  increases by a multiple  equal to the
Exchange  Number,  that such post  Reverse  Split price will be  sustained.  The
Reverse  Split will increase the number of  stockholders  of the Company who own
odd-lots (less than 100 shares).  Stockholders who hold odd-lots  typically will
experience an increase in the cost of selling  their shares,  as well as greater
difficulty  in  effecting  such sales.  Also,  the  possibility  does exist that
liquidity could be adversely affected by the reduced number of shares that would
be outstanding after the Reverse Split. Consequently,  there can be no assurance
that the Reverse Split will achieve the desired  results that have been outlined
above.

Procedure for Effecting Reverse Split and Exchange of Stock Certificates

         If the Amendment is approved by the Company's stockholders,  and if the
Board  of  Directors  still  believes  that  the  Reverse  Split  is in the best
interests  of the  Company  and its  stockholders,  the  Company  will  file the
Amendment  with the  Secretary of State of the State of Delaware at such time as
the Board has determined the  appropriate  Exchange  Number and the  appropriate
effective time for such split.  The Board may delay  effecting the Reverse Split
until June 30, 1999 without resoliciting such stockholder approval.  The Reverse
Split will become  effective on the date of filing the Amendment (the "Effective
Date").  Beginning on the Effective  Date,  each  certificate  representing  Old
Shares will be deemed for all  corporate  purposes to evidence  ownership of New
Shares. To the extent a stockholder would otherwise be entitled to a fraction of
a share, the Company will pay cash for fractional interests as described below.

         As soon as practicable  after the Effective Date,  stockholders will be
notified  that the Reverse  Split has been  effected  and of the exact  Exchange
Number.  The Company's  transfer agent will act as the Company's  exchange agent
(the "Exchange  Agent") to act for holders of Common Stock in  implementing  the
exchange of their certificates. Holders of Old Shares will be asked to surrender
to the  Exchange  Agent  certificates  representing  Old Shares in exchange  for
certificates representing New Shares in accordance with the procedures to be set
forth in a letter of transmittal to be sent by the Company.  No new certificates
will be issued to a stockholder  until such  stockholder  has  surrendered  such
stockholders outstanding certificate(s) together with the properly completed and
executed  letter of transmittal to the Exchange Agent.  Stockholders  should not
destroy  any stock  certificate  and should not  submit any  certificates  until
requested to do so.

Fractional Shares

         No scrip or fractional  certificates  will be issued in connection with
the  Reverse  Split.  Stockholders  who  otherwise  would be entitled to receive
fractional  shares because they hold a number of Old Shares not evenly divisible
by the Exchange Number,  will be entitled,  upon surrender to the Exchange Agent
of certificates representing such shares, to a cash payment in lieu thereof at a
price equal to the fraction to which the stockholder would otherwise be entitled
multiplied by the closing price of the Class A Common Stock,  as reported in The
Wall Street  Journal,  on the Effective Date (or if such price is not available,
the  average of the last bid and ask prices of the Class A Common  Stock on such
day or other price  determined  by the Board of  Directors).  The ownership of a
fractional  interest will not give the holder thereof any voting,  dividend,  or
other rights except to receive payment therefor as described herein.

         Stockholders  should  be aware  that,  under  the  escheat  laws of the
various jurisdictions where stockholders reside, where the Company is domiciled,
and where the funds will be deposited,  sums due for  fractional  interests that
are not timely  claimed after the  Effective  Date may be required to be paid to
the designated agent for each such jurisdiction,  unless correspondence has been
received by the Company or the Exchange Agent concerning ownership of such funds
within  the  time  permitted  in  such  jurisdiction.  Thereafter,  stockholders
otherwise  entitled  to  receive  such  funds  will have to seek to obtain  them
directly from the state to which they were paid.


                                       -6-

<PAGE>

No Dissenter's Rights

         Under Delaware law, stockholders are not entitled to dissenter's rights
with respect to the proposed Amendment.

Federal Income Tax Consequences of the Reverse Split

         The following is a summary of certain  material U.S. federal income tax
consequences  of the Reverse Split to a U.S.  citizen or individual  resident in
the U.S. for federal income tax purposes, a corporation or partnership organized
under the laws of the U.S. or a state of the U.S.,  a trust in which one or more
U.S.  persons  have the  authority to control all  substantial  decisions of the
trust  and a U.S.  court  is able  to  exercise  primary  supervision  over  the
administration  of the trust, or an estate subject to U.S. federal income tax on
all of its income regardless of source (each, a "U.S.  Holder"),  who holds such
stockholder's  Old Shares as a capital  asset.  The  discussion  is based on the
provisions of the U.S.  federal  income tax law as of the date hereof,  which is
subject to change retroactively as well as prospectively.  The discussion is for
general  information only and does not purport to address all relevant  concerns
to a U.S. Holder. In addition,  it does not discuss any state, local, foreign or
minimum income or other U.S. federal tax consequences.  The following discussion
is not tax advice.  Each stockholder  should consult with such stockholder's own
tax advisor with respect to the consequences of the Reverse Split.

         No gain or loss should be recognized  by a  stockholder  of the Company
upon such  stockholder's  exchange of Old Shares for New Shares  pursuant to the
Reverse  Split  (except to the extent of any cash received in lieu of a fraction
of a New Share).  Cash  payments in lieu of a  fractional  New Shares  should be
treated as if the  fractional  share  were  issued to the  stockholder  and then
redeemed by the Company for cash. A Company  stockholder  receiving such payment
should  recognize  gain or loss equal to the  difference,  if any,  between  the
amount of cash  received and the  stockholder's  basis in the  fractional  share
(determined as provided  below).  Such gain or loss will be capital gain or loss
if the  payment  of cash in lieu of the  fractional  share is a mere  mechanical
rounding off of fractions and not separately  bargained for  consideration,  and
the payment is "not  essentially  equivalent to a dividend"  with respect to the
stockholder under the federal income tax law. For this purpose, a payment is not
essentially  equivalent to a dividend if it results in a "meaningful  reduction"
in the stockholder's percentage interest in the Company, taking into account the
constructive  ownership rules and redemptions of fractional  shares from all the
stockholders. The Internal Revenue Service has ruled publicly that any reduction
in the percentage  interest of a small minority  stockholder in a  publicly-held
corporation who exercises no control over corporate  affairs should constitute a
meaningful reduction.

         The aggregate tax basis of the New Shares received in the Reverse Split
(including any fraction of a New Share deemed to have been received) will be the
same as the  stockholder's  aggregate  tax  basis  in the Old  Shares  exchanged
therefor.  The stockholder's  holding period for the New Shares will include the
period  during  which the  stockholder  held the Old Shares  surrendered  in the
Reverse Split.

Required Vote

         Authorization of the proposed  Amendment  requires the affirmative vote
of the holders of a majority of all  outstanding  shares of Class A Common Stock
and Class B Common  Stock,  voting  together  as one class,  with Class A Common
Stock  having one vote per share and Class B Common  Stock  having ten votes per
share.

         The Board of Directors  unanimously  recommends that  stockholders vote
FOR this proposal.





                                       -7-

<PAGE>
                                   PROPOSAL 2.

                    APPROVAL OF ISSUANCE OF ADDITIONAL SHARES
                  UPON CONVERSION OF 5% CONVERTIBLE DEBENTURES

                                    General

         On May 20,  1998,  the Company  completed a private  placement to three
unaffiliated  investors  (the  "Investors")  of an aggregate of $4,000,000 of 5%
Convertible  Debentures due May 20, 2001 (the  "Debentures") and three series of
Warrants to purchase up to an aggregate of 261,228 shares  (subject to reduction
in certain instances) of the Company's Class A Common Stock at an exercise price
of $1.9194 per share (the "Warrants").

         The  Debentures  have  been  convertible  to the  extent  of 25% of the
principal  amount thereof  commencing on September 17, 1998,  with an additional
25% of the principal amount of the Debentures becoming first convertible on each
of October 17,  1998,  November  16,  1998 and  December  16,  1998  (subject to
potential  acceleration in certain instances) at a conversion price equal to 87%
(if converted before November 17, 1998), 86% (if converted  between November 17,
1998 and February 14, 1999), 85% (if converted between February 15, 1999 and May
20, 1999) or 84% (if converted after May 20, 1999), respectively, of the average
of the closing  bid prices of the  Company's  Class A Common  Stock for the five
consecutive  trading days  immediately  preceding  the date of conversion of the
Debentures;  provided,  however,  that in no event may the  conversion  price be
greater  than $1.9375 per share,  which was 125% of such average  price over the
five  consecutive  trading days prior to the  consummation  of the  transaction.
Interest on the Debentures is payable only on maturity,  conversion,  redemption
or when other payment is made on the  Debentures  in cash or, if registered  for
resale under the Securities Act of 1933, as amended (the  "Securities  Act"), in
shares of the Company's Class A Common Stock valued at the applicable  Debenture
conversion   price.   Any  Debenture   outstanding  on  May  20,  2001  will  be
automatically  converted as of that date.  In addition,  the Company may require
conversion of outstanding Debentures after May 20, 2000 if the closing bid price
of its Class A Common Stock on the trading day immediately  preceding its giving
of notice of conversion to Debentureholders is at least $3.0625.

Purpose of the Additional Issuance Proposal

         The rules of Nasdaq require  companies,  the stocks of which are quoted
thereon, to obtain stockholder approval prior to issuing, in a transaction other
than in a public  offering,  a number of shares of common  stock equal to 20% or
more of its common  stock or voting power  outstanding  before the issuance at a
price less than the greater of the book or market value of the stock.

         To meet this requirement,  the Company and the Investors agreed that in
the event the Company would be required to issue more than  4,000,000  shares of
its  Class  A  Common  Stock  upon  conversion  of all of  the  Debentures  (the
"Conversion Limit"), the Company will have the option of: (i) issuing additional
shares  of Common  Stock  but only if (x)  stockholder  approval  (being  sought
herein) has been  obtained or  stockholder  approval is not required in order to
comply with  applicable  rules of the market upon which its Class A Common Stock
is traded and (y) the  additional  shares are  registered  for resale  under the
Securities  Act or (ii)  paying  cash to the  holder in an  amount  equal to the
principal  amount of  Debentures  being  converted  plus an amount  equal to the
number of shares of Class A Common Stock that would be otherwise  issuable  upon
conversion of the Debentures  multiplied by the  difference  between the highest
sales price of the  Company's  Common  Stock on the date of  conversion  and the
applicable Debenture conversion price.

         The  purpose  of the  Additional  Issuance  Proposal  is to enable  the
Company (upon  registering such additional  shares under the Securities Act), to
enable the Company to utilize its option to issue shares of Class A Common Stock
upon conversion of the Debentures  should the Conversion Limit be reached,  thus
enabling the Company to utilize its available cash for operations and to develop
products.



                                       -8-

<PAGE>



         A vote against the Additional  Issuance  Proposal by stockholders  will
not  effect  the  rights of the  Investors,  who  would,  if the  Company  would
otherwise be required to issue in excess of 4,000,000 shares, be able to require
the Company to redeem  Debentures  otherwise  convertible at a redemption  price
equal to, in effect,  that which the  Investors  could have received if they had
been able to  convert  the  Debentures  and,  at the time of their  election  to
convert the Debentures, sold the shares otherwise issuable to them.

Required Vote

         The  affirmative  vote of a  majority  of the  shares of Class A Common
Stock and Class B Common Stock  present,  in person or by proxy,  at the Meeting
and entitled to vote on this proposal,  voting together as one class, with Class
A Common  Stock  having one vote per share and Class B Common  Stock  having ten
votes per share, will be required to adopt this proposal. The Board of Directors
recommends that stockholders vote FOR approval of this proposal.


                                  MISCELLANEOUS

Stockholder Proposals

         From  time to time  stockholders  may  present  proposals  which may be
proper  subjects for inclusion in the proxy statement and form of proxy relating
to that meeting. In order to be considered,  such proposals must be submitted in
writing on a timely basis.  Stockholder proposals intended to be included in the
Company's  proxy  statement  and form of proxy  relating to the  Company's  next
Annual Meeting of Stockholders must be received at 1375 Akron Street,  Copiague,
New  York  11726,  by  January  15,  1999.  Any such  proposals,  as well as any
questions relating thereto, should be directed to the Secretary of the Company.

Solicitation of Proxies

         The cost of  preparing,  assembling  and  mailing the Notice of Special
Meeting,  this Proxy  Statement  and Proxies is to be borne by the Company.  The
Company will also reimburse  brokers who are holders of record of Class A Common
Stock for their expenses in forwarding Proxies and Proxy soliciting materials to
the  beneficial  owners of such  shares.  In  addition  to the use of the mails,
Proxies may be solicited without extra  compensation by directors,  officers and
employees  of  the  Company  by  telephone,   telecopy,  telegraph  or  personal
interview.  The Company has retained W.F.  Doring & Co.,  Inc.,  150 Bay Street,
Jersey City,  New Jersey 07302 to aid in the  solicitation  of Proxies.  For its
services,   W.F.  Doring  &  Co.,  Inc.  will  receive  a  fee  of  $2,500  plus
reimbursement for certain out-of-pocket expenses.

                                            By Order of the Board of Directors,

                                             /s/       Timothy J. Roach

                                                       Timothy J. Roach
                                                       Secretary
October 2, 1998



                                       -9-

<PAGE>



                                    Exhibit A


                  Section of the Company's Restated Certificate of Incorporation
is to be  amended  to add the  following  immediately  after the  present  first
paragraph  thereof  (which sets forth the number and par value of the  Company's
authorized capital stock, none of which is being amended):


                           "Effective  12:01  a.m.  on , 19 , each ( ) shares of
                  Class A  Common  Stock  then  issued  shall  be  automatically
                  combined  into  one  share  of  Class A  Common  Stock  of the
                  Corporation  and each ( ) shares of Class B Common  Stock then
                  issued shall be automatically combined into one share of Class
                  B  Common  Stock  of  the  Corporation.   There  shall  be  no
                  fractional shares issued. In lieu thereof,  each fraction of a
                  share  that  would  otherwise  be issued to  holders of record
                  thereof  shall be  entitled  to receive  payment of $ per full
                  share (after giving effect to the  combination)  multiplied by
                  such fraction (rounded to the nearest cent)."


                                      -10-

<PAGE>


                       AMERICAN BIOGENETIC SCIENCES, INC.
          PROXY FOR SPECIAL MEETING OF STOCKHOLDERS - NOVEMBER 11, 1998

           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

         The undersigned hereby appoints,  as proxies for the undersigned,  AIDA
PADILLA,  TIMOTHY J. ROACH and  LEONARD W.  SUROFF,  or any one or more of them,
with full  power of  substitution,  to vote all shares of the  capital  stock of
American  Biogenetic  Sciences,  Inc. (the  "Company")  which the undersigned is
entitled to vote at the  Special  Meeting of  Stockholders  of the Company to be
held on Wednesday,  November 11, 1998, at 10:30 a.m.  Eastern  Standard Time, at
the  Huntington  Hilton,  598 Broad Hollow Road,  Melville,  New York and at any
adjournments or  postponements  thereof,  receipt of Notice of which meeting and
the Proxy  Statement  accompanying  the same being  hereby  acknowledged  by the
undersigned,  upon the  matters  described  in the Notice of  Meeting  and Proxy
Statement  and upon such other  business as may properly come before the meeting
and any  adjournments  or  postponements  thereof,  hereby  revoking any proxies
heretofore given.

         Each  properly  executed  proxy  will be voted in  accordance  with the
specifications  made on the reverse side hereof. If no specifications  are made,
the proxies will be voted FOR each of Proposals 1 and 2.


                                 (continued and to be signed on reverse side)




                       

<PAGE>

         A vote FOR each of  Proposals  1 and 2 is  recommended  by the Board of
Directors.

1.      To  authorize  an Amendment to the  Company's  Restated  Certificate  of
        Incorporation  in order to effect a combination  (reverse  split) of the
        Company's outstanding Class A Common Stock and Class B Common Stock.


                            FOR                      AGAINST             ABSTAIN

                            [  ]                     [  ]                [  ]



2.      To approve the  issuance of  additional  shares of Class A Common  Stock
        upon conversion of the Company's 5% Convertible Debentures.


                            FOR                      AGAINST             ABSTAIN
         
                            [  ]                     [  ]                [  ]





                                                   Dated:________________, 1998


                                                   _____________________________
                                                     (SIGNATURE OF STOCKHOLDER)


                                                   _____________________________
                                                     (SIGNATURE OF STOCKHOLDER)


                                                   NOTE:  Please  sign your name
                                                   or names exactly as set forth
                                                   hereon.   For  jointly  owned
                                                   shares,   each  owner  should
                                                   sign. If signing as attorney,
                                                   executor,      administrator,
                                                   trustee or  guardian,  please
                                                   indicate   the   capacity  in
                                                   which you are acting. Proxies
                                                   executed   by    corporations
                                                   should  be  signed  by a duly
                                                   authorized officer and should
                                                   bear the corporate seal.

              PLEASE DATE AND SIGN THIS PROXY AND MAIL IT PROMPTLY
           IN THE ENCLOSED ENVELOPE. NO POSTAGE IS REQUIRED IF MAILED
                              IN THE UNITED STATES.


                



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission